NT5E and neoplasm: When tumor cells were tested for the expression levels of the immune inhibitory ligands, there was no significant difference in the expression levels of Fas-L and CD73 among these tumor cells, suggesting that these inhibitory molecules are not associated with resistance to antitumor immunity in this setting.